{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:43:51Z","timestamp":1784684631198,"version":"3.55.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2020.00139","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:03:03Z","timestamp":1585908183000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Sudden Cardiac Death in Children Affected by Cardiomyopathies: An Update on Risk Factors and Indications at Transvenous or Subcutaneous Implantable Defibrillators"],"prefix":"10.3389","volume":"8","author":[{"given":"Valeria","family":"Rella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Crotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The incidence of pediatric cardiomyopathy in two regions of the United States","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1161\/CIRCULATIONAHA.104.530303","article-title":"National Australian childhood cardiomyopathy S. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study","volume":"112","author":"Nugent","year":"2005","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1161\/CIRCULATIONAHA.106.635128","article-title":"National Australian Childhood Cardiomyopathy S. Clinical features and outcomesof childhood dilated cardiomyopathy: results from a national population-based study","volume":"114","author":"Daubeney","year":"2006","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1161\/CIRCULATIONAHA.113.002767","article-title":"National Australian Childhood Cardiomyopathy S. Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy","volume":"128","author":"Alexander","year":"2013","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ppedcard.2007.11.006","article-title":"The pediatric cardiomyopathy registry: 1995\u20132007","volume":"25","author":"Wilkinson","year":"2008","journal-title":"Prog Pediatr Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.hfc.2010.05.002","article-title":"The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years","volume":"6","author":"Wilkinson","year":"2010","journal-title":"Heart Fail Clin"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1067\/mhj.2000.103933","article-title":"Design and implementation of the North American pediatric cardiomyopathy registry","volume":"139","author":"Grenier","year":"2000","journal-title":"Am Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e003450","DOI":"10.1161\/JAHA.116.003450","article-title":"Natural history of dilated cardiomyopathy in children","volume":"5","author":"Puggia","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.healun.2015.01.980","article-title":"Management of children with dilated cardiomyopathy in The Netherlands: implications of a low early transplantation rate","volume":"34","author":"den Boer","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/oxfordjournals.aje.a009291","article-title":"Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland","volume":"146","author":"Arola","year":"1997","journal-title":"Am J Epidemiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951115000943","article-title":"Lessons learned from the Pediatric Cardiomyopathy Registry (PCMR) Study Group","volume":"25","author":"Wilkinson","year":"2015","journal-title":"Cardiol Young"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1161\/CIRCULATIONAHA.112.104638","article-title":"Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry","volume":"126","author":"Webber","year":"2012","journal-title":"Circulation"},{"key":"B14","article-title":"National center on Birth Defects and Developemental Disabilities","volume-title":"Centers for Disease Control and Prevention (CDC)","author":"Botto","year":"2004"},{"key":"B15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jacc.2019.05.022","article-title":"Phenotypic manifestations of arrhythmogenic cardiomyopathy in children and adolescents","volume":"74","author":"DeWitt","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJM199604183341607","article-title":"Sudden death from cardiac causes in children and young adults","volume":"334","author":"Liberthson","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.hrthm.2013.11.006","article-title":"Sudden cardiac death in children and adolescents between 1 and 19 years of age","volume":"11","author":"Pilmer","year":"2014","journal-title":"Heart Rhythm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.111.076810","article-title":"Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review","volume":"126","author":"Meyer","year":"2012","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ppedcard.2017.03.003","article-title":"Prevention of sudden cardiac death in children and young adults","volume":"45","author":"Aro","year":"2017","journal-title":"Prog Pediatr Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.110.004622","article-title":"Incidence of sudden cardiac death in National Collegiate Athletic Association athletes","volume":"123","author":"Harmon","year":"2011","journal-title":"Circulation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCEP.113.001376","article-title":"Pathogeneses of sudden cardiac death in National Collegiate Athletic Association athletes","volume":"7","author":"Harmon","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jacc.2011.01.049","article-title":"Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance","volume":"58","author":"Eckart","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccep.2017.07.008","article-title":"Sherwin, Charles I. Berul. Sudden cardiac death in children and adolescents","volume":"9","author":"Elizabeth","year":"2017","journal-title":"Card Electrophysiol Clin"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"17","author":"Priori","year":"2015","journal-title":"Eur Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1161\/CIR.0000000000000616","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2009.02388.x","article-title":"Implantable cardioverter defibrillator criteria for primary and secondary prevention of pediatric sudden cardiac death","volume":"32","author":"Berul","year":"2009","journal-title":"PACE"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy","volume":"61","author":"Maron","year":"2013","journal-title":"J Am College Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1177\/2047487317702519","article-title":"Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis","volume":"24","author":"Norrish","year":"2017","journal-title":"Eur J Preventive Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jamacardio.2018.0789","article-title":"Long-term outcomes of pediatric-onset hypertrophic cardiomyopathy and age-specific risk factors for lethal arrhythmic events","volume":"3","author":"Maurizi","year":"2018","journal-title":"JAMA Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1093\/europace\/euz118","article-title":"A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy","volume":"21","author":"Norrish","year":"2019","journal-title":"Europace"},{"key":"B31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jacep.2015.08.004","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy in the pediatric population: clinical characterization and comparison with adult-onset disease","volume":"1","author":"Te Riele","year":"2015","journal-title":"JACC: Clin Electrophisiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz669","article-title":"Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis","author":"Corrado","year":"2019","journal-title":"Eur Heart J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1055\/s-0039-1697914","volume":"68","author":"Ferreiro-Marzal","year":"2020","journal-title":"Thorac Cardiovasc Surg"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.hrthm.2016.01.001","article-title":"Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts","volume":"13","author":"Lambiase","year":"2016","journal-title":"Heart Rhythm"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/S0735-1097(01)01568-6","article-title":"Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin","volume":"38","author":"Protonotarios","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1161\/CIR.0b013e318276ce9b","article-title":"2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"127","author":"Epstein","year":"2013","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1054\/S1071-9164(03)00128-3","article-title":"Implantable cardioverter-defibrillators n pediatric and complex congenital heart disease patients awaiting heart transplant","volume":"9","author":"Dubin","year":"2003","journal-title":"J Card Fail"},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ppedcard.2015.01.002","article-title":"Cardiomyopathies in Noonan syndrome and the other RASopathies","volume":"39","author":"Gelb","year":"2015","journal-title":"Prog Pediatr Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/S0140-6736(13)61685-2","article-title":"Pediatric Cardiomyopathy Registry Study G. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry","volume":"382","author":"Lipshultz","year":"2013","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jacc.2009.03.051","article-title":"Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children","volume":"54","author":"Decker","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1161\/CIR.0b013e318223e2bd","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/S0735-1097(99)00421-0","article-title":"A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment","volume":"34","author":"Ostman-Smith","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10741-018-09767-w","article-title":"Review on sudden death risk reduction after septal reduction therapies in hypertrophic obstructive cardiomyopathy","volume":"24","author":"Rigopoulos","year":"2019","journal-title":"Heart Failure Review."},{"key":"B45","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jamacardio.2019.2861","article-title":"Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids)","volume":"4","author":"Norrish","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1161\/CIRCHEARTFAILURE.111.964395","article-title":"Conduction abnormalities in pediatric patients with restrictive cardiomyopathy","volume":"5","author":"Walsh","year":"2012","journal-title":"Circ Heart Fail."},{"key":"B47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0002-9149(02)02522-5","article-title":"Outcome of idiopathic restrictive cardiomyopathy in children","volume":"90","author":"Weller","year":"2002","journal-title":"Am J Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.athoracsur.2013.01.014","article-title":"Pediatric heart transplantation for congenital and restrictive cardiomyopathy","volume":"95","author":"Murtuza","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S1053-2498(01)00334-5","article-title":"Clinical, electrocardiographic, and histologic correlations in children with dilated cardiomyopathy","volume":"20","author":"Nugent","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"B50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/ijms17040486","article-title":"The impact of specific viruses on clinical outcome in children presenting with acute heart failure","volume":"17","author":"Gagliardi","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0735-1097(03)00648-X","article-title":"Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults","volume":"42","author":"Bowles","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N Engl J Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00424-011-0946-1","article-title":"Cytoskeletal protein kinases: titin and its relations in mechanosensing","volume":"462","author":"Gautel","year":"2011","journal-title":"Pflugers Arch"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jacc.2013.11.059","article-title":"Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry","volume":"63","author":"Everitt","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1161\/CIRCHEARTFAILURE.109.902833","article-title":"Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry","volume":"3","author":"Foerster","year":"2010","journal-title":"Circ Heart Fail"},{"key":"B56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/ehf2.12082","article-title":"British Congenital Cardiac A. Heart failure from heart muscle disease in childhood: a 5\u201310 year follow-up study in the UK and Ireland","volume":"3","author":"Andrews","year":"2016","journal-title":"ESC Heart Fail"},{"key":"B57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ppedcard.2014.10.005","article-title":"Do selection criteria for children with dilated cardiomyopathy enrolled in national registries explain differences in outcomes?","volume":"37","author":"Weintraub","year":"2014","journal-title":"Prog Pediatr Cardiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2004.04.035","article-title":"Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation","volume":"44","author":"Tsirka","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"JAMA"},{"key":"B60","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jpeds.2014.04.055","article-title":"Heart failure in children: etiology and treatment","volume":"165","author":"Rossano","year":"2014","journal-title":"J Pediatr"},{"key":"B61","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cardfail.2014.10.011","article-title":"Pediatric versus adult cardiomyopathy and heart failure\u2013related Hospitalizations: a value-based analysis","volume":"21","author":"Wittlieb-Weber","year":"2015","journal-title":"J Card Fail"},{"key":"B62","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/CIRCRESAHA.116.309386","article-title":"Pediatric cardiomyopathies","volume":"121","author":"Lee","year":"2017","journal-title":"Circ Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/CIRCULATIONAHA.110.973826","article-title":"Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry","volume":"124","author":"Alvarez","year":"2011","journal-title":"Circulation"},{"key":"B64","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/CIRCHEARTFAILURE.109.906875","article-title":"BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial","volume":"3","author":"Auerbach","year":"2010","journal-title":"Circ Heart Fail"},{"key":"B65","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cardfail.2015.06.381","article-title":"Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: results from the pediatric cardiomyopathy registry","volume":"21","author":"Jefferies","year":"2015","journal-title":"J Card Fail"},{"key":"B66","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0735-1097(00)00755-5","article-title":"Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis","volume":"36","author":"Oechslin","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.113.002511","article-title":"Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center","volume":"127","author":"Brescia","year":"2013","journal-title":"Circulation."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/eurheartj\/ehz311","article-title":"Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry","volume":"40","author":"Crotti","year":"2019","journal-title":"Eur Heart J"},{"key":"B69","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s00246-015-1327-x","article-title":"Arrhythmogenic right ventricular cardiomyopathy\/dysplasia (ARVC\/D): review of 16 pediatric cases and a proposal of modified pediatric criteria","volume":"37","author":"Deshpande","year":"2016","journal-title":"Pediatr Cardiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.carpath.2004.03.609","article-title":"Naxos disease and Carvajal syndrome: Cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy","volume":"13","author":"Protonotarios","year":"2004","journal-title":"Cardiovasc Pathol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/14779072.2019.1657831","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"17","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"B73","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1016\/j.ijcard.2013.04.177","article-title":"A case of lamin A\/C mutation cardiomyopathy with overlap features of ARVC: a critical role of genetic testing","volume":"168","author":"Valtuille","year":"2013","journal-title":"Int J Cardiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.hrthm.2010.09.073","article-title":"Pediatric ICD utilization in the United States from 1997 to 2006","volume":"8","author":"Burns","year":"2011","journal-title":"Heart Rhythm"},{"key":"B76","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00246-010-9866-7","article-title":"Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease","volume":"32","author":"Von Bergen","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2459\/JCM.0000000000000395","article-title":"Implantable cardioverter defibrillator therapy in young patients with cardiomyopathies and channelopathies: a single Italian centre experience","volume":"17","author":"Migliore","year":"2016","journal-title":"J Cardiovasc Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10840-018-0451-y","article-title":"Efficacy and safety of non-transvenous cardioverter defibrillators in infants and young children","volume":"54","author":"M\u00fcller","year":"2018","journal-title":"J Interv Cardiac Electrophisiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"EFFORTLESS Investigator Group. Implant and midterm outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: the EFFORTLESS Study","volume":"70","author":"Boersma","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijcard.2015.09.083","article-title":"Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease","volume":"203","author":"Bordachar","year":"2016","journal-title":"Int J Cardiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijcard.2016.12.187","article-title":"Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy","volume":"231","author":"Maurizi","year":"2017","journal-title":"Int J Cardiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e002488","DOI":"10.1161\/JAHA.115.002488","article-title":"Subcutaneous implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy: an initial experience","volume":"5","author":"Weinstock","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B84","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/CIRCEP.114.001623","article-title":"Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT)","volume":"7","author":"Ruwald","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.hrthm.2018.01.004","article-title":"Predictors of electrocardiographic screening failure for the subcutaneous implantable cardioverter-defibrillator in children: a prospective multicenter study","volume":"15","author":"Campbell","year":"2018","journal-title":"Heart Rhythm"},{"key":"B86","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/jce.12343","article-title":"Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening","volume":"25","author":"Olde Nordkamp","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.hrthm.2014.04.025","article-title":"Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator","volume":"1","author":"Groh","year":"2014","journal-title":"Heart Rhythm"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/pace.12233","article-title":"Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers","volume":"36","author":"Pettit","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/europace\/eus388","article-title":"Implantable cardioverter defibrillator therapy in pediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation","volume":"15","author":"Griksaitis","year":"2013","journal-title":"Europace"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/europace\/euy139","article-title":"Subcutaneous implantable cardioverter-defibrillator: is it ready for use in children and young adults? A single-centre study","volume":"20","author":"Silvetti","year":"2018","journal-title":"Europace"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/eurheartj\/eht167","article-title":"Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator","volume":"34","author":"Klein","year":"2013","journal-title":"Eur Heart J"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.115.015677","article-title":"Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)","volume":"132","author":"Kutyifa","year":"2015","journal-title":"Circulation"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2020.00139\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:03:05Z","timestamp":1585908185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2020.00139\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":92,"alternative-id":["10.3389\/fped.2020.00139"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.00139","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"article-number":"139"}}